15-115
AMPK Pathway Explorer Antibody MiniPack
1 mg/mL, Upstate®
Synonym(s):
AMP-Activated Protein Kinase
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
UNSPSC Code:
12161503
eCl@ss:
32161000
NACRES:
NA.41
Recommended Products
biological source
rabbit
Quality Level
antibody form
purified antibody
antibody product type
primary antibodies
clone
polyclonal
species reactivity
rat (07-350SP, 07-363SP, 07-681SP), mouse (07-350SP), human (07-350SP, 07-363SP, 07-681SP)
manufacturer/tradename
Upstate®
concentration
1 mg/mL
technique(s)
activity assay: suitable (kinase and phosphatase)
western blot: suitable
UniProt accession no.
shipped in
dry ice
Gene Information
human ... PRKAA1(5562)
mouse ... Hsf3(245525)
General description
Pathway Explorer Antibody MiniPack:
Each Pathway Explorer Antibody Minipack contains three related antibodies as part of a signaling cascade or a combination of total and phosphorylated forms of key signaling targets. Each of the three antibodies are 30% the original pack size. Full size versions of each of the Pathway Explorer antibodies are available for sale individually under the same catalog number with the removal of “SP” off of each one (e.g. 05-591SP can be ordered as 05-591).
AMPK:
AMP-activated protein kinase (AMPK) is a metabolic and stress-sensing kinase that regulates homeostasis, and a key target for treating Type 2 diabetes and obesity. AMPK exists as a heterotrimeric complex comprised of catalytic alpha subunits (62 kDa) and non-catalytic beta and gamma subunits. Alpha subunit has at least two isoforms (alpha 1 and alpha 2) which differ in their subcellular localization and AMP-dependence. AMPK is phosphorylated by upstream kinases, AMPK Kinase (AMPKK) and LKB1 which results in its activation. Active AMPK regulates metabolism by phosphorylating rate-limiting enzymes in metabolic pathways and controlling gene expression. Phosphorylation of threonine 172 in the activation loop of the alpha subunit is a key determinant of AMPK activity.
*See full size versions for corresponding references.
Each Pathway Explorer Antibody Minipack contains three related antibodies as part of a signaling cascade or a combination of total and phosphorylated forms of key signaling targets. Each of the three antibodies are 30% the original pack size. Full size versions of each of the Pathway Explorer antibodies are available for sale individually under the same catalog number with the removal of “SP” off of each one (e.g. 05-591SP can be ordered as 05-591).
AMPK:
AMP-activated protein kinase (AMPK) is a metabolic and stress-sensing kinase that regulates homeostasis, and a key target for treating Type 2 diabetes and obesity. AMPK exists as a heterotrimeric complex comprised of catalytic alpha subunits (62 kDa) and non-catalytic beta and gamma subunits. Alpha subunit has at least two isoforms (alpha 1 and alpha 2) which differ in their subcellular localization and AMP-dependence. AMPK is phosphorylated by upstream kinases, AMPK Kinase (AMPKK) and LKB1 which results in its activation. Active AMPK regulates metabolism by phosphorylating rate-limiting enzymes in metabolic pathways and controlling gene expression. Phosphorylation of threonine 172 in the activation loop of the alpha subunit is a key determinant of AMPK activity.
*See full size versions for corresponding references.
Specificity
07-681SP: AMPKα phosphorylated on Thr172.
07-363SP: AMP-Activated Protein Kinase alpha 2 (AMPKα2).
07-350SP: AMPKα1
07-363SP: AMP-Activated Protein Kinase alpha 2 (AMPKα2).
07-350SP: AMPKα1
07-681SP: Expected to cross-react with mouse based on 100% sequence homology.
Cross Reactivty
Varies. See individual Data Sheets
Varies. See individual Data Sheets
Immunogen
Epitope: 07-350SP and 07-363SP: Internal
Application
Research Category
Signaling
Apoptosis & Cancer
Signaling
Apoptosis & Cancer
Research Sub Category
Insulin/Energy Signaling
Insulin/Energy Signaling
This Antibody pack contains Anti-AMPK α1 Antibody, Anti-AMPKα2 Antibody, Anti-phospho-AMPKα Antibody(Thr172).
Packaging
Each vial is 30% the size of the parent catalog number
Components
07-350SP Anti-AMPK α1; 60 µg
07-363SP Anti-AMPKα2; 60 µg
07-681SP Anti-phospho-AMPKα (Thr172); 60 µg
07-363SP Anti-AMPKα2; 60 µg
07-681SP Anti-phospho-AMPKα (Thr172); 60 µg
Quality
07-681SP:Routinely evaluated by immunoblot on RIPA lysates from overnight starved HEK293 cells and partially purified rat liver AMPK.
Western Blot Analysis:
0.5-2 μg/mL of this lot detected phospho-AMPK α in RIPA lysates from overnight serum starved HEK293 cells and partially purified rat liver AMPK. Signal was reduced after treatment of lysate with λ-phosphatase.
07-363SP: Routinely evaluated by immunoblot in a rat liver preparation.
Western Blot Analysis:
1-2 μg/mL of this lot detected AMPK α2 in a rat liver preparation.
07-350SP: Routinely evaluated by immunoblot in RIPA lysates from non-stimulated A431 cells.
Western Blot Analysis:
0.5-2 μg/mL of this lot detected AMPK α1 in RIPA lysates from non-stimulated A431 cells.
Western Blot Analysis:
0.5-2 μg/mL of this lot detected phospho-AMPK α in RIPA lysates from overnight serum starved HEK293 cells and partially purified rat liver AMPK. Signal was reduced after treatment of lysate with λ-phosphatase.
07-363SP: Routinely evaluated by immunoblot in a rat liver preparation.
Western Blot Analysis:
1-2 μg/mL of this lot detected AMPK α2 in a rat liver preparation.
07-350SP: Routinely evaluated by immunoblot in RIPA lysates from non-stimulated A431 cells.
Western Blot Analysis:
0.5-2 μg/mL of this lot detected AMPK α1 in RIPA lysates from non-stimulated A431 cells.
Target description
~63 kDa;
Physical form
3 individual tubes containing either Anti-AMPK α1; Anti-AMPKα2; or Anti-phospho-AMPKα (Thr172)
Format: Purified
Protein A purified
Storage and Stability
Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variability in freezer temperatures below -20°C may cause glycerol-containing solutions to become frozen during storage.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variability in freezer temperatures below -20°C may cause glycerol-containing solutions to become frozen during storage.
Analysis Note
Control
For 07-681SP use HEK293 cells or rat liver AMPK.
For 07-363SP use Rat liver preparation.
For 07-350SP use A431cell lysate, or lysate of HeLa cells treated with heat shock.
For 07-681SP use HEK293 cells or rat liver AMPK.
For 07-363SP use Rat liver preparation.
For 07-350SP use A431cell lysate, or lysate of HeLa cells treated with heat shock.
Legal Information
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nikolaos Nikolaou et al.
Metabolism: clinical and experimental, 99, 67-80 (2019-07-23)
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome. Steroid hormones and bile acids are potent regulators of hepatic carbohydrate and lipid metabolism. Steroid 5β-reductase (AKR1D1) is highly expressed in human liver where it inactivates steroid hormones
Yiran Cui et al.
International journal of molecular sciences, 18(7) (2017-07-05)
Stroke is the second most common cause of death worldwide. A systematic description and characterization of the strokes and the effects induced in the hippocampus have not been performed so far. Here, we analysed the protein expression in the hippocampus
Xiaoyu Gao et al.
Infection and immunity, 86(1) (2017-10-25)
Postfermented Pu-erh tea (PE) protects against metabolic syndrome (MS), but little is known regarding its underlying mechanisms. Animal experiments were performed to determine whether the gut microbiota mediated the improvement in diet-induced MS by PE and its main active components
The influence of carbohydrate-protein co-ingestion following endurance exercise on myofibrillar and mitochondrial protein synthesis.
Leigh Breen,Andrew Philp,Oliver C Witard,Sarah R Jackman,Anna Selby,Ken Smith,Keith Baar et al.
The Journal of Physiology null
Claudia Tonini et al.
Nutrients, 13(1) (2021-01-21)
A major problem of aging is the disruption of metabolic homeostasis. This is particularly relevant in the brain where it provokes neurodegeneration. Caloric restriction is a physiologic intervention known to delay the deleterious consequences of aging in several species ranging
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service